CRISPR Therapeutics AG
CRSP$56.94▲ 9.33% 24h
CRISPR Therapeutics AGCRSP$56.94
+$23.63(+70.92%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$5.47B
P/E ratio
—
EPS (diluted)
$-6.47
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$3.51M
Net income
$-581.60M
Net margin
-16569.8%
Gross margin
—
Dividends & financials
CRISPR Therapeutics AG (CRSP) reported revenue of $3.51M and net income of $-581.60M, or $-6.47 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.